Managing Director Jim Hesburgh comments on increased mergers and acquisitions activity in the clinical research organization market.
Thu, Sep 12, 2013
Managing Director Jim Hesburgh comments on increased mergers and acquisitions activity in the clinical research organization market.
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.